200 related articles for article (PubMed ID: 23796720)
1. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
Zhang P; Song K; Li L; Yukuwa K; Kong B
Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
Haiyan S; Lin W; Shuhua H; Wang W
Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
[No Abstract] [Full Text] [Related]
3. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
[TBL] [Abstract][Full Text] [Related]
4. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
8. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
9. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
10. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
[TBL] [Abstract][Full Text] [Related]
11. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
12. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
Zheng J; Xia E; Li TC; Sun X
J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
[TBL] [Abstract][Full Text] [Related]
13. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
[TBL] [Abstract][Full Text] [Related]
14. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
[TBL] [Abstract][Full Text] [Related]
16. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
17. An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.
Zhang H; Cao B; Tong J; Guo J; Zheng J; Zhu L; Niu Z; Chen L
BMC Womens Health; 2022 Nov; 22(1):451. PubMed ID: 36384588
[TBL] [Abstract][Full Text] [Related]
18. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
Yang X; Zhang X; Lin B; Feng X; Aili A
Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
20. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
